Human Genome Sciences (Nasdaq: HGSI) is a commercially focused biopharmaceutical company with one potentially major product approved by FDA in March 2011 and a broad pipeline of novel drugs in late- and mid-stage development. More »

Recent News More » 07/16/12 GSK to acquire Human Genome Sciences for US$14.25 per share in cash GSK to acquire full ownership of BENLYSTA®, albiglutide and darapladib Acquisition will be accretive to GSK core earnings in 2013 Tender offer amended to US$14.25 per share and extended until 27 July 2012 LONDON--(BUSINESS WIRE)--Jul. 16, 2012-- GlaxoSmithKline plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced that the companies have entered into a definiti...  07/11/12 FYI From Human Genome Sciences: GlaxoSmithKline Announces Positive Data from Harmony 8 Phase 3 Trial and Completion of Clinical Registration Package for Albiglutide in Type 2 Diabetes ROCKVILLE, Md.--(BUSINESS WIRE)--Jul. 11, 2012-- Attached is a press release issued earlier today by GlaxoSmithKline, announcing that data have been received from the Phase 3 Harmony 8 study and from the event-driven meta-analysis for assessment of cardiovascular safety conducted across the albiglutide clinical program in type 2 diabetes. These data are the final elements required to complete the clinical registration package. A...  07/10/12 Human Genome Sciences Announces Resubmission of Raxibacumab BLA to FDA FDA acknowledges receipt and sets PDUFA action date of December 15, 2012 ROCKVILLE, Md.--(BUSINESS WIRE)--Jul. 10, 2012-- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for raxibacumab, a treatment for inhalational anthrax, and has established December 15, 2012 as the P...  Upcoming Events More » There are currently no events scheduled.

Stock Quote HGSI (Common Stock) Exchange NASDAQ GS (US Dollar) Price $14.24 Change (%) 0.00 (0.00%) Volume 2,900 Data as of 08/02/12 4:00 p.m. ET Minimum 20 minute delay Refresh quote What's New   Annual Report 2011

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Human Genome Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.